Professor Lau Chak-sing, Vice-President of the University of Hong Kong (HKU) and Dean of Medicine, stated that the university is actively recruiting top talent. Earlier, HKU visited prestigious institutions such as Oxford and Cambridge in the UK to attract scholars, receiving resumes from 30 professors and academics. These individuals are drawn to Hong Kong's development opportunities, particularly its close ties with mainland China, where they see rapid advancements in science and technology.
HKU is also in discussions with the University of Cambridge's Medical School to explore collaboration opportunities, including allowing HKU medical students to pursue doctoral programs at Cambridge during their enrichment year.
Speaking on a radio program, Lau noted that Hong Kong's universities and medical schools rank among the world's best, with strong investment prospects in the biotech sector. He emphasized that Hong Kong, as an international city with a low-tax system and the advantage of being "backed by the motherland," benefits from the Greater Bay Area's population of over 80 million, making it an attractive hub for foreign investment.
Lau also highlighted that clinical drug research conducted at the clinical trial centers of Hong Kong's two medical schools is recognized by the US, EU, and China. This means new drugs developed in Hong Kong can be used globally, while also facilitating the future introduction of overseas-developed drugs into the mainland market.
(Source: Wen Wei Po)
Related News:
HKU president stresses academic substance, nurturing China's talent, bridging global understanding
HKU scholars participate in China's Tianwen-3 Mars exploration mission
Comment